SS

Sylvana Stinnett

Financial Administrator at Aster Insights

Sylvana Stinnett is an experienced financial professional with a robust background in corporate accounting and financial administration. Currently serving as a Financial Administrator at M2Gen since 2006, Sylvana previously held the position of Director of Corporate Accounting at HMSHost from 1999 to May 2005. Earlier in their career, Sylvana worked at Bose Corporation as a Cost Analyst and GL Accountant from 1987 to 1999. Sylvana holds an MBA in Business Administration from Assumption University, obtained between 1989 and 1993, and a BS in Accounting from the University of Massachusetts Lowell, completed from 1985 to 1987.

Location

Tampa, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Aster Insights

We believe that personalized medicine starts with a complete view of an individual across their lifetime. Our company was founded in 2006 on the unique principle that informed consent from patients entrusting us with a lifetime connection to their health information, paired with deep partnerships across academia and the life sciences industry, would unlock critical advances in curing cancer. Aster Insights leads the Oncology Research Information Exchange Network (ORIEN®), a consortium of the nation’s leading academic cancer centers that conduct Total Cancer Care®, the world’s largest and longest running observational research study in oncology. TCC® serves as the foundation for novel insights that power oncology breakthroughs. As a long-time innovator in oncology, Aster Insights has world-class expertise in accelerating the life cycle of oncology medical product development. Our solutions are based on scientific and clinical intelligence and strengthened by our unique partnership with patients, academia, and industry. We empower our partners to uncover new targets and biomarkers, enhance cancer detection, deepen our understanding of new treatments, discover new indications, and accelerate clinical trials. Together, we are changing the way cancer is studied, treated, and prevented.


Industries

Employees

51-200

Links